Skip to main content
. 2021 Sep 14;20:15330338211038492. doi: 10.1177/15330338211038492

Figure 2.

Figure 2.

NANOG promotes cancer cell characteristics in ESCC by activating IL-6/STAT3 signaling. (A and B) Expression of IL-6/STAT3, etc was detected by western blotting (A. overexpression and B. knockdown). (C) qPCR tests were used to determine the mRNA expression of NANOG and IL-6 for ectopic expression of different doses of NANOG. (D) Comparison of p-JAK2, total STAT3, p-STAT3, and IL-6 expression by immunoblotting for ectopic expression of different NANOG doses in Eca-109 cells. (E) The level of IL-6 secreted into the growth medium upon ectopic NANOG expression (lower panel) was detected using an ELISA kit, and compared with that of standard samples (upper panel) (*P < .05; **P < .01; ***P < .001).

Abbreviations: ESCC, esophageal squamous cell carcinoma; STAT3, signal transducer and activator of transcription 3; IL-6, interleukin 6; qPCR, quantitative real-time PCR; ELISA, enzyme-linked immunosorbent assay; p-JAK2, phospho-Janus kinase 2.